Single and Multiple Dose Escalation Trial of an Intravenous Antibiotic RC-01
Clinical trial NCT03832517 · TERMINATED
Trial details
- NCT number
- NCT03832517
- Sponsor
- Recida Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-14
- Primary completion
- 2019-04-22
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.